Ignite Creation Date:
2024-05-06 @ 8:55 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02852629
Status:
COMPLETED
Last Update Posted:
2017-09-18
First Post:
2016-02-15
Brief Title:
Assessment of a Tool for Decision Making in Case of Worsening Condition of Cancer Patients
Sponsor:
University Hospital Grenoble
Organization:
University Hospital Grenoble
Study Overview
Official Title:
Assessment of a Tool for Decision Making in Case of Worsening Condition of Cancer Patients
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CBP-Aggrav
Brief Summary:
Observational two year study to evaluate the utility of a decision-support sheet on how to proceed in case of aggravation of a patients condition with advanced disease
Detailed Description:
Prospective and multicenter study conducted in the Rhône-Alpes-Auvergne area All patients suffering from lung cancer admitted to a pulmonology unit in 2014 will be included This document will be used if a decision to withhold life-sustaining treatment is decided Investigators will assess the relationship between the planned intensity of care and those established when the patient develops an organ failure Patient characteristics and factors associated with proposed levels and types of care will be analyzed Patient and family opinions will be obtained after 3 months The number of subjects is 468
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None